SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-133757
Filing Date
2024-05-08
Accepted
2024-05-08 07:00:30
Documents
15
Period of Report
2024-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d820381d8k.htm   iXBRL 8-K 24668
2 EX-99.1 d820381dex991.htm EX-99.1 87728
6 GRAPHIC g820381g0507214759037.jpg GRAPHIC 2139
  Complete submission text file 0001193125-24-133757.txt   250868

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA veru-20240508.xsd EX-101.SCH 2846
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20240508_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20240508_pre.xml EX-101.PRE 11258
18 EXTRACTED XBRL INSTANCE DOCUMENT d820381d8k_htm.xml XML 3620
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 24924174
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)